(3R,4S)/(3S,4R)-3-(4-Fluorobenzyl)-4-hydroxy-1-(4-methoxybenzyl)-3-(4-(methylsulfonyl)phenyl)pyrrolidin-2-one

ID: ALA5177981

PubChem CID: 168277016

Max Phase: Preclinical

Molecular Formula: C26H26FNO5S

Molecular Weight: 483.56

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc(CN2C[C@@H](O)[C@@](Cc3ccc(F)cc3)(c3ccc(S(C)(=O)=O)cc3)C2=O)cc1

Standard InChI:  InChI=1S/C26H26FNO5S/c1-33-22-11-5-19(6-12-22)16-28-17-24(29)26(25(28)30,15-18-3-9-21(27)10-4-18)20-7-13-23(14-8-20)34(2,31)32/h3-14,24,29H,15-17H2,1-2H3/t24-,26-/m1/s1

Standard InChI Key:  FNYFCMKBTSFCJY-AOYPEHQESA-N

Molfile:  

 
     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
   -4.1302   -2.1903    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3052   -2.1903    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7177   -1.4758    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4385   -0.5610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0225    0.0254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1844   -1.3485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6405   -1.3485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8973   -0.5645    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2280   -0.0776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2268    0.7471    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6823   -0.3106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2946   -0.8635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1196   -1.6684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7312   -2.2210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5171   -1.9673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6881   -1.1559    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0752   -0.6068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1302   -2.5193    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9586   -3.3264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1927   -2.1735    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1552   -0.9694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8667   -0.5500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5828   -0.9577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5880   -1.7834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8710   -2.1997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1578   -1.7897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3079   -3.0176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0302    0.8513    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3163    1.2689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3237    2.0943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0431    2.5014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7571    2.0773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7463    1.2536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0520    3.3264    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  1  6
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  4  1  0
  9 10  2  0
  8 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 15 18  1  0
 18 19  1  0
  6 20  1  1
  4 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24  2  1  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
  2 27  1  0
  5 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 28  1  0
 31 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5177981

    ---

Associated Targets(non-human)

pol Human immunodeficiency virus type 1 protease (9113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 483.56Molecular Weight (Monoisotopic): 483.1516AlogP: 3.12#Rotatable Bonds: 7
Polar Surface Area: 83.91Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.95CX Basic pKa: CX LogP: 3.09CX LogD: 3.09
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.56Np Likeness Score: -0.62

References

1. Kojima E, Iimuro A, Nakajima M, Kinuta H, Asada N, Sako Y, Nakata Z, Uemura K, Arita S, Miki S, Wakasa-Morimoto C, Tachibana Y..  (2022)  Pocket-to-Lead: Structure-Based De Novo Design of Novel Non-peptidic HIV-1 Protease Inhibitors Using the Ligand Binding Pocket as a Template.,  65  (8.0): [PMID:35416651] [10.1021/acs.jmedchem.1c02217]

Source